2021
- ISIRV-WHO Virtual Conference: COVID-19, Influenza and RSV: Surveillance-Informed Prevention and Treatment
- Dates: 19–21 October 2021
- Format: Virtual
- Focus: Global response to SARS-CoV-2, including antivirals, vaccines, and surveillance strategies; treatment and prevention of influenza and RSV.
- Report: Published in Antiviral Research
2020
- Therapeutics for COVID-19: Antiviral Group Virtual Conference
- Dates: 6–8 October 2020
- Format: Virtual
- Focus: Advances in the development of antivirals and other therapeutics for COVID-19; improved clinical management.
- Report: Available
2019
- AVG Polymerase Inhibitor Resistance Meeting
- Dates: 7–8 August 2019
- Location: Atlanta, USA
- Focus: Impact of resistance to new antivirals targeting influenza RNA polymerase.
- Report: Available
2018
- 6th ISIRV-AVG Conference: Advances in Respiratory Virus Therapeutics
- Dates: 13–15 November 2018
- Location: Washington DC, USA
- Focus: Advancements in therapeutics for respiratory viruses.
- Report: Available
- Influenza 2018: Centenary of the 1918 Pandemic
- Dates: 24–26 June 2018
- Location: London, UK
- Focus: Lessons from the 1918 pandemic; pandemic preparedness.
2017
- 5th ISIRV-AVG Conference: Prevention and Treatment of Respiratory Viral Infections
- Dates: 14–16 June 2017
- Location: Shanghai, China
- Focus: Strategies for prevention and treatment of respiratory viral infections.
- Report: Available
2016
- Training Workshop: Genetic Analyses of Influenza Viruses
- Date: 29 August 2016
- Location: Northwestern University, Chicago
- Organizers: ISIRV-AVG, GISAID, WHO
- Focus: Genetic analysis techniques for influenza viruses.
- Program: Available
2015
- Training Workshop: Genetic Analyses of Influenza Viruses
- Dates: 21–22 November 2015
- Location: Hong Kong
- Organizers: ISIRV-AVG, GISAID, WHO, Hong Kong Polytechnic University
- Focus: Genetic analysis techniques for influenza viruses.
- Report: Available
- 4th ISIRV-AVG Conference: Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench to Bedside
- Dates: 2–4 June 2015
- Location: Austin, Texas
- Focus: Development and clinical application of novel antiviral therapies.
- Report: Available
- Workshop: Next Generation Sequencing of Viruses
- Dates: 20–21 May 2015
- Location: Paris, France
- Organizers: ISIRV-AVG, GISAID, PREDEMICS
- Focus: Advancements in sequencing technologies for viruses.
- Report: Available
2014
- 3rd ISIRV-AVG Conference: Influenza and Other Respiratory Virus Infections: Advances in Clinical Management
2013
- AVG Discussion Meeting: Clinical Trial Endpoints for Studies of Antivirals in Hospitalised and At-Risk Patients
- Date: 8 September 2013
- Location: Cape Town, South Africa
- Focus: Endpoints in clinical trials for antiviral studies.
- Resources: Agenda and summary report
- Training Workshop: Sequence Analysis and Detection of Antiviral Resistance
- Date: 7 September 2013
- Location: Cape Town, South Africa
- Organizers: ISIRV-AVG, GISAID, WHO
- Focus: Techniques for detecting antiviral resistance.
- Report: Available
2012
- 2nd ISIRV-AVG Conference: Severe Influenza: Burden, Pathogenesis and Management
- Dates: 29–31 October 2012
- Location: Hanoi, Vietnam
- Organizers: ISIRV-AVG, National Institute of Hygiene and Epidemiology
- Focus: Burden, pathogenesis, and management of severe influenza.
- Report: Meeting summary, program and abstract book, and addendum
2011
- Inaugural Meeting: Influenza Antivirals: Efficacy and Resistance
- Dates: 8–10 November 2011
- Location: Rio de Janeiro, Brazil
- Organizers: ISIRV-AVG, Oswaldo Cruz Foundation
- Focus: Efficacy and resistance of influenza antivirals.
- Report: available
2010
- NISN Overview: Antiviral Drug Resistance Data
- Date: September 2010
- Location: Hong Kong
- Focus: Overview of antiviral drug resistance data presented at Options for the Control of Influenza VII.
- Report: Available
